Search Results - "Chetner, M"

The Initial Results in Muscle‐Invading Bladder Cancer of RTOG 95‐06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5‐Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response by Kaufman, Donald S., Winter, Kathryn A., Shipley, William U., Heney, Niall M., Chetner, Michael P., Souhami, Luis, Zlotecki, Robert A., Sause, William T., True, Lawrence D.

“…Purpose. To assess the safety, tolerance, and efficacy of transurethral surgery plus concomitant cisplatin, 5‐fluorouracil (5‐FU), and radiation therapy in…”
Get full text

Screening for prostatic carcinoma with prostate specific antigen by Brawer, M K, Chetner, M P, Beatie, J, Buchner, D M, Vessella, R L, Lange, P H

“…Prostate specific antigen (PSA), neutral serine protease secreted exclusively by prostatic epithelial cells, has a number of applications in the management of…”
Get more information

Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography by Ellis, W J, Chetner, M P, Preston, S D, Brawer, M K

“…Three tests are commonly used to diagnose prostate carcinoma to date: serum prostate specific antigen (PSA), digital rectal examination and transrectal…”
Get more information

Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia by Chancellor, M B, Gajewski, J, Ackman, C F, Appell, R A, Bennett, J, Binard, J, Boone, T B, Chetner, M P, Crewalk, J A, Defalco, A, Foote, J, Green, B, Juma, S, Jung, S Y, Linsenmeyer, T A, MacMillan, R, Mayo, M, Ozawa, H, Roehrborn, C G, Shenot, P J, Stone, A, Vazquez, A, Killorin, W, Rivas, D A

“…We determine the long-term efficacy and safety of the UroLume stent as minimally invasive treatment for external detrusor-sphincter dyssynergia in spinal cord…”
Get more information

Multicenter trial in North America of UroLume urinary sphincter prosthesis by Chancellor, M B, Rivas, D A, Linsenmeyer, T, Abdill, C A, Ackman, C F, Appell, R A, Bennett, J, Binard, J, Boone, T B, Chetner, M P

“…We investigated the effectiveness and associated complications of treatment with an endoluminal urethral sphincter prosthesis in 153 spinal cord injury men…”
Get more information

Lower urinary tract dysfunction in multiple sclerosis by Mayo, M E, Chetner, M P

“…Previous investigators have shown that in multiple sclerosis failure to empty the bladder was secondary to detrusor-distal sphincter dyssynergia or areflexia…”
Get more information

Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors by Chapman, J D, McPhee, M S, Walz, N, Chetner, M P, Stobbe, C C, Soderlind, K, Arnfield, M, Meeker, B E, Trimble, L, Allen, P S

“…Dunning R3327-AT prostate carcinomas growing in Fischer X Copenhagen rats were treated with interstitial photodynamic therapy (PDT--15 mg/kg Photofrin II 4…”
Get more information

Removal of UroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application by Gajewski, J B, Chancellor, M B, Ackman, C F, Appell, R A, Bennett, J, Binard, J, Boone, T B, Chetner, M P, Crewalk, J A, Defalco, A, Foote, J, Green, B, Juma, S, Jung, S Y, Linsenmeyer, T A, Macaluso, Jr, J N, Macmillan, R, Mayo, M, Ozawa, H, Roehrborn, C G, Schmidt, J, Shenot, P J, Stone, A, Vazquez, A, Killorin, W, Rivas, D A

“…We present the experience of the North American UroLume Multicenter Study Group with removal of the UroLume endoprosthesis. A total of 160 neurologically…”
Get more information

Periurethral implantation of glutaraldehyde cross-linked collagen (Contigen) in women with type I or III stress incontinence: quantitative outcome measures by Moore, K N, Chetner, M P, Metcalfe, J B, Griffiths, D J

“…To evaluate the effectiveness of periurethral collagen (Contigen) implantation as a treatment for stress incontinence, using quantitative measures of urine…”
Get more information

Optical dosimetry for interstitial photodynamic therapy by Arnfield, M R, Tulip, J, Chetner, M, McPhee, M S

“…An approach to photodynamic treatment of tumors is the interstitial implantation of fiber optic light sources. Dosimetry is critical in identifying regions of…”
Get more information

Prostatic abscess after transrectal ultrasound guided biopsy by Sohlberg, O E, Chetner, M, Ploch, N, Brawer, M K

“…We report a case of a diabetic man who had bilateral prostatic abscesses after ultrasound guided biopsy of the prostate. As is typical of prostatic abscesses,…”
Get more information

Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial by Nickel, J C, Downey, J, Johnston, B, Clark, J

“…To our knowledge antibiotics are the most popular choice of therapy for all categories of the chronic prostatitis/chronic pelvic pain syndrome. We determine if…”
Get more information

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors by Scrimger, R A, Murtha, A D, Parliament, M B, Venner, P M, Hanson, J, Houle, G, Chetner, M

“…Population-based cancer registries can permit the study of the survivorship of all patients with a particular diagnosis regardless of patterns of referral and…”
Get more information

CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results by Klotz, Laurence H., Goldenberg, S.Larry, Jewett, Michael, Barkin, Jack, Chetner, Michael, Fradet, Yves, Chin, Joseph, Laplante, Suzanne

“…Objectives. To test the hypothesis that neoadjuvant androgen ablation before radical prostatectomy reduces the likelihood of biochemical progression at 36…”
Get full text

The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model by Grover, S A, Coupal, L, Zowall, H, Rajan, R, Trachtenberg, J, Elhilali, M, Chetner, M, Goldenberg, L

“…We developed an economic model of prostate cancer management from diagnosis until death. We have used the Montreal Prostate Cancer Model to estimate the total…”
Get full text

Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy by Stephenson, Andrew J, Chetner, Michael P, Rourke, Keith, Gleave, Martin E, Signaevsky, M, Palmer, Bruce, Kuan, James, Brock, Gerald B, Tanguay, Simon

“…We characterized relapse patterns in patients with sporadic renal cell carcinoma (RCC) following radical and partial nephrectomy, and developed surveillance…”
Get more information

Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy by Novick, Andrew C.

Get full text

CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group by Klotz, L H, Goldenberg, S L, Jewett, M, Barkin, J, Chetner, M, Fradet, Y, Chin, J, Laplante, S

“…To test the hypothesis that neoadjuvant androgen ablation before radical prostatectomy reduces the likelihood of biochemical progression at 36 months. Two…”
Get full text

The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model by Grover, S A, Coupal, L, Zowall, H, Rajan, R, Trachtenberg, J, Elhilali, M, Chetner, M, Goldenberg, L

“…The incidence of prostate cancer is increasing, as is the number of diagnostic and therapeutic interventions to manage this disease. We developed a Markov…”
Get full text

Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects by Gleave, M E, Goldenberg, S L, Chin, J L, Warner, J, Saad, F, Klotz, L H, Jewett, M, Kassabian, V, Chetner, M, Dupont, C, Van Rensselaer, S

“…A prospective phase 3 trial was initiated to determine whether 8 compared with 3-month neoadjuvant hormonal therapy reduces prostate specific antigen (PSA)…”
Get more information